Published in Kidney Int on July 01, 2002
Macrophage diversity in renal injury and repair. J Clin Invest (2008) 4.41
TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir Res (2005) 4.24
Host responses in tissue repair and fibrosis. Annu Rev Pathol (2012) 2.10
The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol (2010) 2.04
Interleukin-1 participates in the progression from liver injury to fibrosis. Am J Physiol Gastrointest Liver Physiol (2009) 1.72
Epithelial-mesenchymal transition in renal fibrosis - evidence for and against. Int J Exp Pathol (2011) 1.34
Transforming growth factor beta1 induces epithelial-to-mesenchymal transition of A549 cells. J Korean Med Sci (2007) 1.33
Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis. J Am Soc Nephrol (2014) 1.03
Nilotinib attenuates renal injury and prolongs survival in chronic kidney disease. J Am Soc Nephrol (2011) 0.98
Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy. Br J Pharmacol (2011) 0.97
Implication of CD38 gene in podocyte epithelial-to-mesenchymal transition and glomerular sclerosis. J Cell Mol Med (2012) 0.90
Interleukin-1β attenuates myofibroblast formation and extracellular matrix production in dermal and lung fibroblasts exposed to transforming growth factor-β1. PLoS One (2014) 0.89
Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling. Drug Des Devel Ther (2015) 0.87
Epithelial to mesenchymal transition of mesothelial cells in tuberculous pleurisy. Yonsei Med J (2011) 0.79
P2X(7) receptor at the heart of disease. Hippokratia (2010) 0.79
Altered collagen homeostasis in human aortic smooth muscle cells (HAoSMCs) induced by aldosterone. Pflugers Arch (2007) 0.78
Macrophage adhesion on fibronectin evokes an increase in the elastic property of the cell membrane and cytoskeleton: an atomic force microscopy study. Eur Biophys J (2014) 0.76
Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis. Oncotarget (2016) 0.76
Danggui Buxue Tang Attenuates Tubulointerstitial Fibrosis via Suppressing NLRP3 Inflammasome in a Rat Model of Unilateral Ureteral Obstruction. Biomed Res Int (2016) 0.75
Identification of urinary exosomal non-coding RNAs as novel biomarkers in Chronic Kidney Disease. RNA (2016) 0.75
Characterization and Activation of NLRP3 Inflammasomes in the Renal Medulla in Mice. Kidney Blood Press Res (2016) 0.75
Interleukin-1beta as a mediator of tubulointerstitial fibrosis. Kidney Int (2002) 0.75
A potential mode of action for Anakinra in patients with arthrofibrosis following total knee arthroplasty. Sci Rep (2015) 0.75
Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int (2010) 12.06
A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med (2010) 10.33
A randomized trial of a single dose of oral dexamethasone for mild croup. N Engl J Med (2004) 5.02
Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med (2009) 4.35
ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int (2011) 3.88
Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning. Ann Emerg Med (2009) 3.67
Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics (2014) 3.52
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ (2008) 3.35
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97
Cost-effectiveness of epinephrine and dexamethasone in children with bronchiolitis. Pediatrics (2010) 2.68
Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust (2007) 2.68
Cost-effectiveness of initiating dialysis early: a randomized controlled trial. Am J Kidney Dis (2011) 2.62
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2014) 2.35
HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev (2013) 2.21
Relationship between dialysis modality and mortality. J Am Soc Nephrol (2008) 2.06
Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice. Clin Chem Lab Med (2015) 1.98
Dialysis modality preference of patients with CKD and family caregivers: a discrete-choice study. Am J Kidney Dis (2012) 1.97
Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int (2010) 1.89
Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int (2005) 1.83
Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis (2010) 1.81
Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev (2013) 1.77
The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int (2013) 1.75
Vitronectin: growth factor complexes hold potential as a wound therapy approach. J Invest Dermatol (2008) 1.71
Clinical practice guidelines for peritoneal access. Perit Dial Int (2010) 1.71
Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Nephrol Dial Transplant (2009) 1.68
Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev (2014) 1.63
Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination. Am J Kidney Dis (2009) 1.61
Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology (Carlton) (2012) 1.61
Peritoneal small solute clearance is nonlinearly related to patient survival in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int (2009) 1.61
A risk quantification instrument for acute acetaminophen overdose patients treated with N-acetylcysteine. Ann Emerg Med (2005) 1.60
Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with peritoneal dialysis. Perit Dial Int (2007) 1.59
Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department. Cochrane Database Syst Rev (2009) 1.58
Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant (2004) 1.56
Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int (2011) 1.56
Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int (2013) 1.52
HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev (2014) 1.52
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2009) 1.52
The effect of oral iron admiinistration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial. Transplantation (2004) 1.52
High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis. Nephrol Dial Transplant (2007) 1.51
Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int (2009) 1.49
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrol Dial Transplant (2013) 1.47
The frequency of complications associated with the use of multiple-dose activated charcoal. Ann Emerg Med (2003) 1.47
Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog (2011) 1.46
Practice variations in the treatment of febrile infants among pediatric emergency physicians. Pediatrics (2009) 1.45
Nebulized epinephrine for croup in children. Cochrane Database Syst Rev (2011) 1.43
Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA. Nephrology (Carlton) (2005) 1.43
Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ (2012) 1.43
Vascular remodeling in the internal mammary artery graft and association with in situ endothelin-1 and receptor expression. Circulation (2006) 1.42
Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol (2003) 1.41
The Initiating Dialysis Early and Late (IDEAL) study: study rationale and design. Perit Dial Int (2004) 1.40
Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int (2004) 1.38
Patient management by cyclosporine C2 monitoring: not enough science yet to justify the practice. Transplantation (2003) 1.38
Croup in the paediatric emergency department. Paediatr Child Health (2007) 1.38
Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol (2005) 1.37
A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol (2013) 1.36
Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD. Perit Dial Int (2009) 1.34
Review article: Hepatitis B and dialysis. Nephrology (Carlton) (2010) 1.32
Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol (2009) 1.31
Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am J Kidney Dis (2010) 1.31
Molecular cell biology of androgen receptor signalling. Int J Biochem Cell Biol (2009) 1.30
Corticosteroid therapy in IgA nephropathy. J Am Soc Nephrol (2012) 1.30
The impact of automated eGFR reporting and education on nephrology service referrals. Nephrol Dial Transplant (2008) 1.27
Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases. Nephrol Dial Transplant (2010) 1.24
Remote indigenous peritoneal dialysis patients have higher risk of peritonitis, technique failure, all-cause and peritonitis-related mortality. Nephrol Dial Transplant (2011) 1.23
Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis. Kidney Int (2010) 1.22
Changes in serum prolactin, sex hormones and thyroid function with alternate nightly nocturnal home haemodialysis. Nephrology (Carlton) (2012) 1.20
A systematic review on the diagnosis of pediatric bacterial pneumonia: when gold is bronze. PLoS One (2010) 1.18
Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases. BMC Nephrol (2009) 1.16
Peritoneal dialysis practice in Australia and New Zealand: a call to action. Nephrology (Carlton) (2011) 1.16
Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes. Am J Kidney Dis (2009) 1.15
Glucocorticoids for croup. Cochrane Database Syst Rev (2011) 1.13
Outcomes of transplants from patients with small renal tumours, live unrelated donors and dialysis wait-listed patients. Transpl Int (2009) 1.12
Practice variation among pediatric emergency departments in the treatment of bronchiolitis. Acad Emerg Med (2004) 1.12
Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function. Am Heart J (2006) 1.12
Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor. Angiogenesis (2009) 1.11
Epinephrine for bronchiolitis. Cochrane Database Syst Rev (2011) 1.11
Once- versus twice-daily tacrolimus: are the formulations truly equivalent? Drugs (2011) 1.10
Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol (2012) 1.10
Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases. Nephrol Dial Transplant (2009) 1.09
Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies. J Lab Clin Med (2006) 1.08
The impact of extended-hours home hemodialysis and buttonhole cannulation technique on hospitalization rates for septic events related to dialysis access. Hemodial Int (2010) 1.07
A 4-year review of pediatric mental health emergencies in Alberta. CJEM (2009) 1.07
Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J Am Soc Nephrol (2013) 1.06
Compared with younger peritoneal dialysis patients, elderly patients have similar peritonitis-free survival and lower risk of technique failure, but higher risk of peritonitis-related mortality. Perit Dial Int (2011) 1.05
Medicinal herbal extracts -- renal friend or foe? Part one: the toxicities of medicinal herbs. Nephrology (Carlton) (2004) 1.04
The treatment of pediatric gastroenteritis: a comparative analysis of pediatric emergency physicians' practice patterns. Acad Emerg Med (2010) 1.04
Interleukin-1beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism. J Lab Clin Med (2002) 1.03
The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study. BMC Nephrol (2012) 1.02
Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients. Am J Kidney Dis (2004) 1.02
A novel imaging technique to measure capillary-refill time: improving diagnostic accuracy for dehydration in young children with gastroenteritis. Pediatrics (2006) 1.02
Distal tubular epithelial cells of the kidney: Potential support for proximal tubular cell survival after renal injury. Int J Biochem Cell Biol (2007) 1.02
Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients. Br J Clin Pharmacol (2011) 1.02
Association between depression and death in people with CKD: a meta-analysis of cohort studies. Am J Kidney Dis (2013) 1.01
Correlates of subclinical left ventricular dysfunction in ESRD. Am J Kidney Dis (2003) 1.00
When do the aminotransferases rise after acute acetaminophen overdose? Clin Toxicol (Phila) (2010) 0.99
Cytotoxicity of topical antimicrobial agents used in burn wounds in Australasia. ANZ J Surg (2004) 0.98